Drug intelligence / Profile preview

xiao'er liuwei shizhen gel

Development stage: Unknown
Lead developer: Shandong Hanfang Pharmaceutical
Administration: Topical

Overview

Xiao'er Liuwei Shizhen gel (Pediatric Six-Ingredient Eczema Gel) is a topical Traditional Chinese Medicine (TCM) formulation developed by Shandong Hanfang Pharmaceutical for the treatment of pediatric atopic dermatitis. The gel is specifically indicated for patients classified under the TCM syndrome of "damp eczema with accumulation of damp-heat." It is currently undergoing Phase II clinical evaluation in China (Trial ID: CTR20262867) to assess its efficacy and safety compared to an ultra-low-dose control. As a "Six-Ingredient" formula, it utilizes a combination of botanical extracts known for their synergistic anti-inflammatory and anti-pruritic properties to alleviate skin lesions and itching in children.

Other names: Pediatric Six-Ingredient Eczema Gel小儿六味湿疹凝胶

Beyond the preview

Go deeper on xiao'er liuwei shizhen gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiao'er liuwei shizhen gel.

Explore the full profile